CULLINAN ONCOLOGY INC's ticker is CGEM and the CUSIP is 230031106. A total of 82 filers reported holding CULLINAN ONCOLOGY INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $212,983 | +140.6% | 23,534 | +186.1% | 0.00% | – |
| Q2 2023 | $88,512 | -49.8% | 8,226 | -52.3% | 0.00% | – |
| Q1 2023 | $176,355 | +1384.6% | 17,239 | +1431.0% | 0.00% | – |
| Q4 2022 | $11,879 | -30.1% | 1,126 | -15.5% | 0.00% | – |
| Q3 2022 | $17,000 | -57.5% | 1,333 | -57.3% | 0.00% | – |
| Q2 2022 | $40,000 | -64.6% | 3,123 | -71.0% | 0.00% | – |
| Q1 2022 | $113,000 | -87.9% | 10,757 | -82.3% | 0.00% | -100.0% |
| Q4 2021 | $936,000 | +1200.0% | 60,678 | +1813.5% | 0.00% | – |
| Q3 2021 | $72,000 | +227.3% | 3,171 | +265.7% | 0.00% | – |
| Q2 2021 | $22,000 | -78.6% | 867 | -64.9% | 0.00% | – |
| Q1 2021 | $103,000 | – | 2,470 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM BioImpact LLC | 7,648,268 | $69,216,825 | 18.48% |
| CHI Advisors LLC | 3,414,189 | $30,898,410 | 12.25% |
| Nextech Invest Ltd. | 1,221,145 | $11,051,362 | 3.35% |
| TANG CAPITAL MANAGEMENT LLC | 621,138 | $5,621,299 | 0.79% |
| BVF INC/IL | 3,196,701 | $28,930,144 | 0.78% |
| Parkman Healthcare Partners LLC | 438,745 | $3,970,642 | 0.73% |
| Velan Capital Investment Management LP | 75,000 | $678,750 | 0.55% |
| BRAIDWELL LP | 1,908,865 | $17,275,228 | 0.55% |
| Boxer Capital, LLC | 1,074,082 | $9,720,442 | 0.52% |
| DAFNA Capital Management LLC | 127,284 | $1,151,920 | 0.36% |